Graduate student Keito Hoshitsuki, PharmD ’17 was selected as a recipient of the NIH TL1 post-doctoral (Clinical and Translational Science) fellowship award from the Institute for Clinical Research and Education (ICRE) and Clinical and Translational Science Institute (CTSI) at the University of Pittsburgh. The long-term goal of Hoshitsuki’s research is to identify strategies to predict and prevent immune-mediated adverse drug reactions. Hoshitsuki is a first year PittPharmacy graduate student in the Clinical Pharmaceutical Sciences track under the mentorship of Assistant Professor Christian A. Fernandez, PhD.
Graduate student Jonathan Birabaharan was selected as a recipient of the NIH TL1 pre-doctoral fellowship award from the ICRE and CTSI at the University of Pittsburgh. The goal of Birabaharan’s research is to elucidate dose-response relationships between delirium occurrence and sedative use. Birabaharan is a second year PittPharmacy graduate student in the Clinical Pharmaceutical Sciences track under the mentorships of Associate Dean of Graduate and Postdoctoral Programs and Professor of Pharmaceutical Sciences Samuel M. Poloyac, PharmD, PhD, FCCM and Associate Professor Philip Empey, PharmD, PhD.
As part of this competitive and prestigious fellowship program, Hoshitsuki and Birabaharan will conduct multidisciplinary clinical and translational mentored research as well as participate in a career development program.
